GAPP, the Global Alliance for Preventing Pandemics, is an international collaborative public health research center that establishes sustainable infrastructure for infectious disease discovery, surveillance, diagnostics, and response through global capacity building.
While GAPP is focused on scientific development, the impact of GAPP’s mission satisfies a critical international necessity in public health and addresses environmental, animal, community, and medical issues across the globe.
Rapidly unidentified emerging infectious disease resulting from the direct impact of climate change and population growth is causing unchecked widespread disease as well as societal, agricultural, and economic destruction.
The WHO 2023 Working Group on Amendments to the International Health Regulations (2005) has participation from all 194 Member States and will be reviewing over 300 amendments to the IHR, prompted by the COVID-19 pandemic. The group has “stressed the importance of enhancing capacity building, especially in low-income countries; access to benefits arising from sharing pathogens; equitable access to medical countermeasures; and enhanced cooperation and information sharing.”
GAPP’s ability to support laboratory development and provide technical training in global research deserts is essential to satisfying the WHO International Health Regulations of 2005 and fully supports the Working Group’s direction for strengthening international collaboration.
Where We Are
Who We Are
W. Ian Lipkin, MD
- GAPP Director
J. Kenneth Wickiser, PhD
- GAPP Administrative Director
Xiang-Jun Lu, PhD
- Research Scientist
- Project Coordinator II
Dynamics of SARS-CoV-2 variants characterized during different COVID-19 waves in Mali (2023, doi: 10.1016/j.ijregi.2022.11.009)
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19 (2021, doi: 10.1172/JCI150646)
SARS-CoV-2 Sequence Analysis during COVID-19 Case Surge, Liberia, 2021 (doi: 10.3201/eid2712.211818)
Molecular and Serologic Investigation of the 2021 COVID-19 Case Surge Among Vaccine Recipients in Mongolia (2021, doi: 10.1001/jamanetworkopen.2021.48415)
Support the Center for Infection and Immunity
Our work would not be possible without the generous support of our partners